找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hypofractionated and Stereotactic Radiation Therapy; A Practical Guide Orit Kaidar-Person,Ronald Chen Book 20181st edition Springer Interna

[復(fù)制鏈接]
樓主: 喝水
21#
發(fā)表于 2025-3-25 04:18:49 | 只看該作者
Hypofractionated and Stereotactic Radiation TherapyA Practical Guide
22#
發(fā)表于 2025-3-25 10:17:55 | 只看該作者
23#
發(fā)表于 2025-3-25 14:31:20 | 只看該作者
24#
發(fā)表于 2025-3-25 19:47:16 | 只看該作者
ng from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally e978-3-319-92800-5978-3-319-92802-9
25#
發(fā)表于 2025-3-25 22:00:36 | 只看該作者
Book 20181st editioniation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung,? and colorectal.? Conventional radiation therapy and hypofractionat
26#
發(fā)表于 2025-3-26 00:50:34 | 只看該作者
27#
發(fā)表于 2025-3-26 07:14:58 | 只看該作者
28#
發(fā)表于 2025-3-26 11:16:18 | 只看該作者
,?Naturcode? – Natur, Medien und Werte,ing noninvasive. This chapter summarizes the use of hypofractionated RT, focusing on SBRT, for nasopharyngeal carcinoma in the definitive setting where it is used as a boost to traditional EBRT, as well as in the re-irradiation setting.
29#
發(fā)表于 2025-3-26 15:11:27 | 只看該作者
The Physics of Hypofractionation and SRS/SBRT,nes the physics of hypofractionation by starting with definitions and basic premise, reviewing some currently available delivery systems, and finally discussing safety measures and important QA procedures at each step of the treatment process, from simulation to delivery.
30#
發(fā)表于 2025-3-26 16:52:39 | 只看該作者
Glioblastomaation. Patients older than 65–70 with good performance status are candidates for hypofractionated RT ± concurrent and adjuvant temozolomide. Patients with poor performance status can be considered for hypofractionated RT alone, temozolomide alone, or palliative/best supportive care based on MGMT methylation status and overall clinical picture.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 00:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
兴山县| 陵川县| 玉环县| 满城县| 安乡县| 浙江省| 固安县| 门源| 舟山市| 漯河市| 巨鹿县| 洛南县| 同心县| 宜宾县| 新蔡县| 涿州市| 芜湖市| 融水| 惠来县| 伊春市| 墨脱县| 修水县| 唐山市| 宁远县| 青海省| 文昌市| 宁海县| 腾冲县| 斗六市| 宝应县| 新兴县| 宝丰县| 陕西省| 确山县| 海阳市| 台江县| 平安县| 大渡口区| 山阳县| 定边县| 塔城市|